FDA and Regulation

summary text

Edited 4:08

Honest Globe and Biolyte Labs received letters for their marketing practices, as well as for substandard manufacturing practices, according to the Food and Drug Administration.

The Hemp and Hemp-Derived CBD Consumer Protection and Market Protection Act would direct the FDA to outline a clear federal regulatory framework for hemp and hemp-derived products.

The Food and Drug Administration has withdrawn its draft guidance on cannabidiol enforcement policy, in-line with a regulatory freeze as a review of new and pending rules is undertaken by the Biden administration.

The “Regulatory Roadmap for the CBD Industry” conference is slated for Oct. 21 at 10 a.m. Various moderators who will participate in a Q&A with NPA CEO Daniel Fabricant.